Results 271 to 279 of about 100,944 (279)

Tocilizumab

Reactions Weekly, 2020
openaire   +2 more sources

Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease

International Immunopharmacology, 2020
Hamidreza Samaee, Monireh Mohsenzadegan, Shahram Ala   +2 more
exaly  

Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan

Modern Rheumatology, 2016
Omi Watanabe, Mayumi Mochizuki, Nobuhiko Ishizuka   +2 more
exaly  

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

Acta Ophthalmologica, 2016
Sukhum Silpa-Archa, Merih Oray, C Stephen Foster   +2 more
exaly  

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

International Immunopharmacology, 2005
Masahiko Mihara, Makoto Okazaki, Shigeto Kawai   +2 more
exaly  

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

Modern Rheumatology, 2009
Norihiro Nishimoto, Kazuhiko Yamamoto, Shinichi Kawai   +2 more
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, Cesar Ramos-Remus   +2 more
exaly  

No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study

Seminars in Arthritis and Rheumatism, 2018
Seoyoung C Kim, Daniel H Solomon, Khaled Sarsour   +2 more
exaly  

Tocilizumab: The first interleukin-6-receptor inhibitor

American Journal of Health-System Pharmacy, 2008
exaly